52 Firmen mit Ergebnissen für "怎么查酒店开房信息- 查询微信44 1"

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

10094 Ergebnisse für "怎么查酒店开房信息- 查询微信44 1" unter ETH Entrepreneurship

1

... 1 Material Safety EKC Technology Data Sheet EKC Technology 2520 Barrington Court Hayward, CA 94545 ... -1133 Phone 1-510-784-9105 Fax: 1-510-784-9181 DuPont Electronic Technologies 1 . PRODUCT AN D COMPAN Y ... 1 ... 1 Material Safety EKC Technology Data Sheet EKC Technology 2520 Barrington Court Hayward, CA 94545 ... 1 ...

Slide 1

... Slide 1 COSMO Activities in the Climate and Water Cycle Group Sven Kotlarski, Daniel Lüthi, Jürg ... Nov 2013 1. 2. Fig.: E. Zubler Sven Kotlarski COSMO User Workshop 27th Nov 2013 1. Regional Climate ... Slide 1 ... Slide 1 COSMO Activities in the Climate and Water Cycle Group Sven Kotlarski, Daniel Lüthi, Jürg ... Slide 1 ...

Mehr Ergebnisse

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

11616 Ergebnisse für "怎么查酒店开房信息- 查询微信44 1" unter University of Zurich

Microsoft Word - 05_2007101800709203_FullPaper_查.doc

... , Michael.Schaepman, Jan.Clevers)@wur.nl Commission VII, WG VII/ 1 KEY WORDS: Chlorophyll Content, Non-Photosynthetic ... . * Corresponding author. 1. INTRODUCTION Foliar concentration of the main photosynthetic pigments chlorophyll a and ... , Michael.Schaepman, Jan.Clevers)@wur.nl Commission VII, WG VII/ 1 KEY WORDS: Chlorophyll Content, Non-Photosynthetic ... . * Corresponding author. 1. INTRODUCTION Foliar concentration of the main photosynthetic pigments chlorophyll a and ... Microsoft Word - 05_2007101800709203_FullPaper_ .doc ...

Layout 1

... Layout 1 empirically validated local theories on musical education and musical learn- ing processes ... investigate how lessons could be improved Competence-oriented music lessons to improve teaching 1 PROFILE ... Layout 1 ... Layout 1 empirically validated local theories on musical education and musical learn- ing processes ... Layout 1 ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

2187 Ergebnisse für "怎么查酒店开房信息- 查询微信44 1" unter University Hospital Zurich​, Research and Education Office

Folie 1

... Folie 1 Stem Cell Transplantation for AL Amyloidosis Ute Hegenbart, MD Amyloidosis Center ... University Heidelberg Medical Dept. V / Hematology / Stem cell transplant Unit Zürich, 19.06.2014, 1 ... Folie 1 ... Folie 1 Stem Cell Transplantation for AL Amyloidosis Ute Hegenbart, MD Amyloidosis Center ... Folie 1 ...

Slide 1

... Slide 1 A retrospective database study investigating days spent in acute care hospitals during the ... with about 20% market share and patient record review identified 2086 patients, which had at least 1 ... Slide 1 ... Slide 1 A retrospective database study investigating days spent in acute care hospitals during the ... Slide 1 ...

Mehr Ergebnisse

InSphero AG

http://www.insphero.com  

8952 Schlieren, Wagistrasse 27

 +41 44 515049-0
 info@insphero.com

InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.

InSphero AG

Wagistrasse 27

8952 Schlieren

289 Ergebnisse für "怎么查酒店开房信息- 查询微信44 1" unter InSphero AG

Slide 1

... 4 h 7 2 h 1 44 h IC 5 0 = 8 3 .3 M IC 5 0 = 4 7 .9 M IC 5 0 = 2 5 .0 M 0 . 1 1 1 0 1 0 0 0 5 0 1 0 ... Slide 1 1 1 0 1 0 0 1 0 0 0 0 5 0 1 0 0 1 5 0 2 0 0 S ita x s e n ta n (µ M ) C e ll v ia b il it y ... 4 h 7 2 h 1 44 h IC 5 0 = 8 3 .3 M IC 5 0 = 4 7 .9 M IC 5 0 = 2 5 .0 M 0 . 1 1 1 0 1 0 0 0 5 0 1 0 ... Slide 1 1 1 0 1 0 0 1 0 0 0 0 5 0 1 0 0 1 5 0 2 0 0 S ita x s e n ta n (µ M ) C e ll v ia b il it y ... Slide 1 ...

Folie 1

... Folie 1 INTRODUCTION Defeating the animal: Alternative systems for neurotoxicity testing Julia ... Leist2, Christoph van Thriel1 1 IfADo, Dortmund, Germany 2 University of Konstanz, Konstanz, Germany 3 ... Folie 1 INTRODUCTION Defeating the animal: Alternative systems for neurotoxicity testing Julia ... Leist2, Christoph van Thriel1 1 IfADo, Dortmund, Germany 2 University of Konstanz, Konstanz, Germany 3 ... Folie 1 ...

Mehr Ergebnisse

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

19988 Ergebnisse für "怎么查酒店开房信息- 查询微信44 1" unter Somagenetix

Folie 1

... Folie 1 U N I V E R S I T Ä T S M E D I Z I N B E R L I N Sex in basic research – concepts in the ... 0 1 2 3 4 Years after AVR 0.8 1 0.6 0.4 0.2 Su rv iv al (% ) 0 Type of LV hypertrophic remodeling ... Folie 1 ... Folie 1 U N I V E R S I T Ä T S M E D I Z I N B E R L I N Sex in basic research – concepts in the ... Folie 1 ...

1-s2.0-S0167701219307444-main.pdf

... bacterial strains were incubated for 14 to 20 hours at 37°C ± 1°C. S. canis was incubated for 44 to 46 hours ... bacterium and growth phase, and were exposed to CAAP for 30 s, 1 min and 2 min. CAAP treatment resulted in ... bacterial strains were incubated for 14 to 20 hours at 37°C ± 1°C. S. canis was incubated for 44 to 46 hours ... 1-s2.0-S0167701219307444-main.pdf ... 1-s2.0-S0167701219307444-main.pdf ...

Mehr Ergebnisse

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

2477 Ergebnisse für "怎么查酒店开房信息- 查询微信44 1" unter Roche Glycart AG

OP-EHEA190412 1..61

... OP-EHEA190412 1..61 2019 ESC Guidelines for the diagnosis and management of acute pulmonary ... Mainz, Building 403, Langenbeckstr. 1, 55131 Mainz, Germany. Tel: þ49 613 117 6255, Fax: þ49 613 117 ... OP-EHEA190412 1..61 ... OP-EHEA190412 1..61 2019 ESC Guidelines for the diagnosis and management of acute pulmonary ... OP-EHEA190412 1..61 ...

1

... 1 ... 1 Science Culture Community Participate Go to roche.com Science Culture Community Participate Go to ... 1 ...

Mehr Ergebnisse

Surgical Fusion Technologies GmbH

https://www.sft-medical.com/  

8952 Schlieren, Wagistrasse 6

 +41 (0)44 204 61 21

Surgical Fusion Technologies is a technology and development company specialized in medical and surgical product innovations. SFT products are based on Suprafusion technology, a disruptive soft tissue fixation system using a unique ultrasonic generator to deliver next-generation anchoring solutions that seek to eliminate anchor micro-motion, leading to greater fixation stability, and improved healing outcomes.

Surgical Fusion Technologies GmbH

Wagistrasse 6

8952 Schlieren

2 Ergebnisse für "怎么查酒店开房信息- 查询微信44 1" unter Surgical Fusion Technologies GmbH

Terms of Service 1 — company

... Phone: +41 (0) 44 204 60 18 Fax: +41 (0) 44 204 61 20 Terms and Conditions By accessing the Surgical ... Terms of Service 1 — company ... Terms of Service 1 — company 0 Skip to Content Home Technology Company Contact Open Menu Close Menu ... Terms of Service 1 — company ...

Contact — company

... : +41 (0) 44 204 60 18 SURGICAL FUSION TECHNOLOGIES Imprint Privacy Contact info@surgical-fusion.com ...

Blutspende SRK Zürich

https://www.blutspendezuerich.ch/  

8952 Schlieren, Rütistrasse 19

 +41 58 272 52 52
 info@zhbsd.ch

The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).

Blutspende SRK Zürich

Rütistrasse 19

8952 Schlieren

304 Ergebnisse für "怎么查酒店开房信息- 查询微信44 1" unter Blutspende SRK Zürich

Folie 1

... Folie 1 IRON DEPLETION DYNAMICS AND SAFETY OF THERAPEUTIC ERYTHROCYTAPHERESIS VERSUS CONVENTIONAL ... ) ). Tolerability and side effects were recorded using a standardized questionaire and a rating system. 1. M ... Folie 1 ... Folie 1 IRON DEPLETION DYNAMICS AND SAFETY OF THERAPEUTIC ERYTHROCYTAPHERESIS VERSUS CONVENTIONAL ... Folie 1 ...

Folie 1

... Folie 1 BLACK AFRICAN VS+ ANTIGEN IS DEFINED BY C733 AND MAY CROSS-REACT WITH RHCE*E/e GENOTYPE ... Stefan Meyer1, Nadine Trost1, Caren Vollmert2, Jochen Gottschalk1, Beat M. Frey1, Christoph Gassner1 1 ... Folie 1 ... Folie 1 BLACK AFRICAN VS+ ANTIGEN IS DEFINED BY C733 AND MAY CROSS-REACT WITH RHCE*E/e GENOTYPE ... Folie 1 ...

Mehr Ergebnisse

Molecular Partners AG

http://www.molecularpartners.com  

8952 Schlieren, Wagistrasse 14

 +41 44 755 77 00

Molecular Partners AG is a clinical-stage biopharmaceutical company, located in Schlieren, Switzerland, that is developing a new class of therapies known as DARPin® therapies.

Molecular Partners AG

Wagistrasse 14

8952 Schlieren

112 Ergebnisse für "怎么查酒店开房信息- 查询微信44 1" unter Molecular Partners AG

Molecular Partners Announces First Patient Dosed in Phase 1 Trial o...

... 1 Trial of MP0310, a Novel Tumor-Localized Immunotherapy October 3, 2019 PDF Version Zurich ... patient has been enrolled and dosed in a Phase 1 first-in-human study of MP0310 as a single agent in ... Molecular Partners Announces First Patient Dosed in Phase 1 Trial of MP0310, a Novel Tumor ... -announces-first-patient-dosed-phase- 1-trial ... Molecular Partners Announces First Patient Dosed in Phase 1 Trial of MP0310, a Novel Tumor ...

Comments on: Molecular Partners Presents Data of MP0250 in an All-C...

... Comments on: Molecular Partners Presents Data of MP0250 in an All-Comer Phase 1-Study in Solid ... an All-Comer Phase 1-Study in Solid Tumor Patients and Updates on Phase 2 Studies Building tomorrow’s ... Comments on: Molecular Partners Presents Data of MP0250 in an All-Comer Phase 1-Study in Solid ... http://www.molecularpartners.com/molecular-partners-presents-data-of-mp0250-in-an-all-comer-phase- 1 ... Comments on: Molecular Partners Presents Data of MP0250 in an All-Comer Phase 1-Study in Solid ...

Mehr Ergebnisse

Kuros Biosciences AG

https://kurosbio.com/  

8952 Schlieren, Wagistrasse 25

 +41 (0)44 733 4747

Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.

Kuros Biosciences AG

Wagistrasse 25

8952 Schlieren

194 Ergebnisse für "怎么查酒店开房信息- 查询微信44 1" unter Kuros Biosciences AG

Kuros Biosciences completes enrolment in Level 1 clinical study of ...

... Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules Preliminary data shows 78 ... % fusion rate vs 42% for autograft and 55-71% for other synthetic bone grafts  Level 1 clinical study ... Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules - Kuros ... https://kurosbio.com/resources/kuros-biosciences-completes-enrolment-in-level- 1-clinical-study-of ... Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules - Kuros ...

Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs M...

...  MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft Schlieren (Zurich ... announced the publication of a peer-reviewed manuscript that details the clinical data of its MAXA Level 1 ... Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in ... -maxa-level- 1-study-outcomes-in-spine-indicating-superiority-over-autograft/ ... Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in ...

Mehr Ergebnisse

Mehr Firmen

Nach oben